mumps vaccines vaccines prevent given majority population decrease complications population effectiveness population vaccinated estimated two doses required long term initial dose recommended months second dose typically given two years six years usage exposure already immune may side effects generally may cause mild pain swelling site injection mild significant side effects evidence insufficient link vaccine complications neurological vaccine given people pregnant poor immune system poor outcomes among children mothers received vaccine pregnancy however even though vaccine developed chicken cells generally safe give egg developed world many countries developing world include immunization programs often combination measles rubella vaccine known formulation previous three varicella chickenpox vaccine known mmrv also countries provided vaccine part immunization areas widespread vaccination carried resulted decline rates almost half billion doses one variety vaccine midtwentieth century mumps infections among children viewed serious public health issue adult men may develop debilitating testicular inflammation posed particular difficulty among closequartered soldiers wartime result world war ii united states government targeted mumps scientific first experimental mumps vaccine licensed developed inactivated virus shortterm improved vaccines became commercially available maurice hilleman merck co took samples mumps virus daughter contracted disease became namesake resulting jeryl lynn building thenrecent advances led vaccines polio measles mumps virus strains developed embryonic hens eggs chick embryo cell resulting strains virus less wellsuited human cells thus said attenuated sometimes referred neuroattenuated sense strains less virulent human neurons wild hillemans work led first effective mumps vaccine called mumpsvax licensed fouryear development set record fastest development new record later surpassed vaccine developed less vaccination mumps become routine mumpsvax included mercks combined mmr vaccine targeted measles rubella along mmr licensed percent american children received combined vaccine us centers disease control prevention cdc recommended mumps immunization part mmr children months age cdc began recommending twodose immunization initial vaccine based inactivated virus subsequent preparations since consist live virus mumps vaccine world health organizations list essential number different types use mumpsvax mercks brand jeryl lynn strain component mercks threevirus mmr vaccine mumps vaccine standard united mumpsvax given subcutaneous injection live virus reconstituted freezedried lyophilized production mumpsvax standalone product ceased cells used culture virus stocks used animal fluids screened extraneous material part vaccine production grown medium solution containing buffered salt vitamins amino acids fetal bovine serum spga sucrose phosphate glutamate human serum albumin neomycin human albumin processing uses cohn cold ethanol fractionation monovalent mumps vaccine mumpsvax remained available us mmr introduced uk replacing mr measles rubella mixed vaccine uklicensed monovalent preparation ever monovalent mumps vaccines available mmr used limited became subject considerable argument end century since parents preferred obtain individually components mmr mixture one mumps vaccine preparation imported united kingdom unlicensed proved essentially immunisation mumps uk became routine commencing mmr aventispasteur brand usual uk needed cold chain major consideration vaccination particularly lessdeveloped countries mumps vaccines normally refrigerated long halflife days degrees httpsenwikipediaorgwikimumpsvaccine